Results

Total Results: 9,992 records

Showing results for "situation monitoring".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-binary-outcomes-evaluation_research.pdf
    March 11, 2013 - This situation is analogous to univariate meta- analysis, where for non-variance-stabilizing link functions
  2. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-binary-outcomes-evaluation_research.pdf
    March 11, 2013 - This situation is analogous to univariate meta- analysis, where for non-variance-stabilizing link functions
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/trauma-informed-care-draft-report.pdf
    January 01, 2024 - cultural, historical, and gender issues (e.g., cultural relevance); incorporating data-driven incident monitoring … Variety of mental health services offered: in-clinic consults, psychotherapy, medication evaluation/monitoring … collaboration, screening/assessment/treatment services, training and workforce development, progress monitoring
  4. www.uspreventiveservicestaskforce.org/home/getfilebytoken/3qpQqeeozW8nV3a4_BWntp
    June 20, 2019 - effectiveness of other interventions (immunizations, more frequent Papanicolaou testing, and routine monitoring … are interventions (antiretroviral treatment, counseling on risky behaviors, immunizations, routine monitoring … A separate report (13) reviews KQs 6, 7c, 9, and portions of 7a (immunizations, routine monitoring and … some interventions (for example, most immuniza- tions, more frequent Papanicolaou testing, routine monitoring
  5. www.ahrq.gov/sites/default/files/wysiwyg/research/findings/final-reports/18987-Nembhard-draft-1.pdf
    April 30, 2015 - Criteria and standards for quality assessment and monitoring. Qual Rev Bull 1986;14:99-108. 20.
  6. www.ahrq.gov/sites/default/files/wysiwyg/research/findings/final-reports/18987-Nembhard-report.pdf
    April 30, 2015 - Criteria and standards for quality assessment and monitoring. Qual Rev Bull 1986;14:99-108. 20.
  7. Data Measures Guide (pdf file)

    www.cpsi.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/mvp/modules/vae/datameasures-guide.pdf
    January 01, 2017 - Choose the analyses that are most appropriate for your site and situation.
  8. cds.ahrq.gov/sites/default/files/reports/AHRQ_Final_Report_2017.pdf
    January 01, 2017 - project has included clinical and technical translation of guidelines into computable CDS, testing and monitoring
  9. Data Measures Guide (pdf file)

    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/mvp/modules/vae/datameasures-guide.pdf
    January 01, 2017 - Choose the analyses that are most appropriate for your site and situation.
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/insulin-analogues-disposition-081229.pdf
    September 01, 2008 - new disposition of comments insulin analogues -- jda revs.xls                                                                                                                                                Comment, by Section Response Executive Summary Comment: A statement under Gaps in Evidence and Future Direction…
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_surveillance.pdf
    August 01, 2012 - brand name, reasons included increase in seizure frequency (19.6% versus 1.6%, p<0.0001); careful monitoring
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_surveillance.pdf
    August 01, 2012 - brand name, reasons included increase in seizure frequency (19.6% versus 1.6%, p<0.0001); careful monitoring
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/nppv-respiratory-failure_executive.pdf
    July 01, 2012 - illness-associated weakness, pneumothorax, delirium, and infections associated with the invasive monitoring
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/meditation_executive.pdf
    January 01, 2014 - In this situation, in which double-blinding has not been feasible, the challenge to execute studies
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/pressure-ulcer-treatment_executive.pdf
    May 01, 2013 - 1 Comparative Effectiveness Review Number 90 Pressure Ulcer Treatment Strategies: Comparative Effectiveness Executive Summary Background Uninterrupted pressure exerted on the skin, soft tissue, muscle, and bone can lead to the development of localized ischemia, tissue inflammation, shearing, anoxia, and …
  16. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/pressure-ulcer-treatment_executive.pdf
    May 01, 2013 - 1 Comparative Effectiveness Review Number 90 Pressure Ulcer Treatment Strategies: Comparative Effectiveness Executive Summary Background Uninterrupted pressure exerted on the skin, soft tissue, muscle, and bone can lead to the development of localized ischemia, tissue inflammation, shearing, anoxia, and …
  17. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/nppv-respiratory-failure_executive.pdf
    July 01, 2012 - illness-associated weakness, pneumothorax, delirium, and infections associated with the invasive monitoring
  18. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/insulin-analogues-disposition-081229.pdf
    September 01, 2008 - new disposition of comments insulin analogues -- jda revs.xls                                                                                                                                                Comment, by Section Response Executive Summary Comment: A statement under Gaps in Evidence and Future Direction…
  19. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_surveillance.pdf
    August 01, 2012 - brand name, reasons included increase in seizure frequency (19.6% versus 1.6%, p<0.0001); careful monitoring
  20. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_surveillance.pdf
    August 01, 2012 - brand name, reasons included increase in seizure frequency (19.6% versus 1.6%, p<0.0001); careful monitoring